Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
BMC Public Health|April 22, 2021
Projections of disability-adjusted life years for major diseases due to a change in vegetable intake in 2017-2040 in JapanShiori Tanaka, Daisuke Yoneoka, Aya Ishizuka, et al.
JAMA Internal Medicine|September 3, 2024
GLP-1 Receptor Agonist Use and Risk of Suicide DeathPeter Ueda, Jonas Söderling, Viktor Wintzell, et al.
RMD Open|January 10, 2019
Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validationLotta Ljung, Peter Ueda, Katherine P Liao, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 7, 2020
Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17Ali Allahyari, Tomas Jernberg, Dominik Lautsch, et al.
BMC Public Health|September 30, 2020
Forecasting disability-adjusted life years for chronic diseases: reference and alternative scenarios of salt intake for 2017-2040 in JapanShuhei Nomura, Daisuke Yoneoka, Shiori Tanaka, et al.
The Lancet. Public Health|March 19, 2023
Neurodegenerative disease among male elite football (soccer) players in Sweden: a cohort studyPeter Ueda, Björn Pasternak, Carl-Emil Lim, et al.
Journal of Internal Medicine|May 31, 2023
Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarctionJessica Schubert, Bertil Lindahl, Håkan Melhus, et al.
BMJ (Clinical Research Ed.)|December 21, 2022
Alcohol related disorders among elite male football players in Sweden: nationwide cohort studyPeter Ueda, Björn Pasternak, Henrik Svanström, et al.
BMJ Open|January 17, 2025
Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profileHannah Coudé Adam, Omid Hajimirsadeghi, Lovisa Krantz, et al.
European Journal of Preventive Cardiology|June 6, 2024
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individualsAli Yari, Peter Ueda, Pia Lundman, et al.
Pageof 9